BreathID® Test: A Non-invasive Modality to Detect Pancreatic Exocrine Insufficiency

PHASE2CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

February 28, 2009

Study Completion Date

March 31, 2009

Conditions
Chronic PancreatitisHealthy Volunteers
Interventions
DRUG

benzoyl-L-tyrosyl-[1-13C]alanine (Bz-Tyr-Ala)

300 mg of powder form dissolved in one cup of tap water prior to breath test

DRUG

benzoyl-L-tyrosyl-[1-13C]alanine (Bz-Tyr-Ala)

300 mg of 13 C di peptide in single dose powder form dissolved in one cup of tap water.

Trial Locations (1)

500 082

Asian Institute of Gastroenterology, Hyderabad, India, Somājigūda

Sponsors
All Listed Sponsors
collaborator

Virginia Commonwealth University

OTHER

collaborator

Asian Institute of Gastroenterology, Hyderabad, India

UNKNOWN

lead

Meridian Bioscience, Inc.

INDUSTRY